Orthofix Medical Inc. (NASDAQ:OFIX) Insider Sells $82,973.00 in Stock

Orthofix Medical Inc. (NASDAQ:OFIX – Get Rating) insider Kevin J. Kenny sold 4,367 shares of Orthofix Medical stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $19.00, for a total transaction of $82,973.00. Following the transaction, the insider now owns 146,307 shares in the company, valued at $2,779,833. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Orthofix Medical Stock Down 0.4 %

NASDAQ OFIX traded down $0.08 during trading on Friday, reaching $18.86. The company’s stock had a trading volume of 161,286 shares, compared to its average volume of 340,905. The stock has a market capitalization of $689.14 million, a PE ratio of -7.61 and a beta of 0.87. Orthofix Medical Inc. has a 1-year low of $13.76 and a 1-year high of $27.91. The business has a 50-day moving average price of $17.95 and a 200-day moving average price of $19.02. The company has a current ratio of 2.98, a quick ratio of 1.37 and a debt-to-equity ratio of 0.10.

Orthofix Medical (NASDAQ:OFIX – Get Rating) last posted its earnings results on Monday, March 6th. The medical device company reported $0.19 EPS for the quarter, topping the consensus estimate of ($0.37) by $0.56. Orthofix Medical had a negative return on equity of 2.14% and a negative net margin of 14.40%. The business had revenue of $122.23 million during the quarter, compared to the consensus estimate of $121.90 million. During the same quarter last year, the company earned $0.27 EPS. On average, research analysts forecast that Orthofix Medical Inc. will post -2.89 earnings per share for the current fiscal year.

Institutional Trading of Orthofix Medical

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Cerity Partners LLC acquired a new position in Orthofix Medical during the first quarter worth approximately $585,000. Quantbot Technologies LP bought a new stake in Orthofix Medical during the first quarter worth $39,000. CWM LLC raised its stake in Orthofix Medical by 433.4% during the fourth quarter. CWM LLC now owns 1,947 shares of the medical device company’s stock worth $40,000 after acquiring an additional 1,582 shares in the last quarter. UBS Group AG lifted its stake in Orthofix Medical by 2,120.8% in the 3rd quarter. UBS Group AG now owns 2,776 shares of the medical device company’s stock valued at $53,000 after purchasing an additional 2,651 shares during the last quarter. Finally, KBC Group NV grew its position in Orthofix Medical by 87.1% during the 1st quarter. KBC Group NV now owns 2,879 shares of the medical device company’s stock worth $48,000 after acquiring an additional 1,340 shares during the last quarter. 98.43% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on shares of Orthofix Medical in a research report on Sunday, May 21st. They set a “buy” rating on the stock.

Orthofix Medical Company Profile

(Get Rating)

Orthofix Medical, Inc engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion.